Toth Financial Advisory’s Aratana Therapeutics, Inc. PETX Stock Holding History

Toth Financial Advisory’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-8,318	Closed	-$43K	–	522
2019 Q2	$43K	Hold	8,318	–	–	0.01%	232
2019 Q1	$30K	Buy	+8,318	New	+$36K	0.01%	238

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Toth Financial Advisory's PETX Position: Q3 2019 in Review

Toth Financial Advisory sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 8,318 shares — an estimated $43K sold.

Toth Financial Advisory first reported a position in PETX in Q1 2019 and held it in 2 quarters. The position peaked at $43K in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Toth Financial Advisory reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Toth Financial Advisory sold 8,318 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $43K.
Toth Financial Advisory first reported a position in Aratana Therapeutics, Inc. in Q1 2019 and held it in 2 quarters.
Toth Financial Advisory's Aratana Therapeutics, Inc. position peaked at $43K in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Toth Financial Advisory's 13F filing for Q3 2019, filed 15 Oct 2019.